Better Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Better Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q1 2023.
  • Better Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $423K, a 15.6% increase year-over-year.
  • Better Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.82M, a 182% increase from 2021.
  • Better Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $646K, a 177% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $423K +$57K +15.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $366K +$332K +976% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $34K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.